Half of America Doesn’t Know This Product Exists. The Other Half Thinks It’s Only for Accidents.

Hadi Radwan runs Asteya as a fully remote company — roughly 80 people, no office — and treats his own biometric data (sleep tracking, continuous glucose monitoring, quarterly bloodwork) with the same discipline he applies to running the business. His stated philosophy: reading a single blood test result in isolation tells you almost nothing; what actually matters is the trend over years, since a doctor telling you “you’re within range” says nothing about whether that range is quietly drifting toward a problem. He draws the analogy directly to his company: if you don’t know your numbers — loss ratios, cost ratios, unit economics — the business is just as exposed as a body nobody’s tracking.

That same self-tracking instinct extends into how he manages his own time as a remote CEO. He takes “firefighter” meetings — internal strategy and problem-solving calls, not investor pitches or board presentations — entirely on foot, phone in hand, specifically to reclaim physical activity lost to eliminating a commute. He practices inbox zero with a hard rule: anything requiring more than three or four minutes of thought gets deferred to the next day, and he never answers email while genuinely angry, on the theory that a clear head produces better decisions than an emotional one.

In Episode 89 of InsurTechTalk, Hadi and I covered why Asteya deliberately rebrands disability insurance as “income insurance,” the specific mechanics of guaranteed renewability that make it a genuinely unusual product, and why he considers the entire first wave of insurtech’s disintermediation thesis fundamentally wrong for this category.

About Hadi Radwan

Hadi Radwan is co-founder of Asteya, an income insurance (disability insurance) technology company targeting the US market, licensed simultaneously as a retail broker, an MGU (managing general underwriter), and a TPA (third-party administrator) across all 50 states. Asteya spent roughly two years in stealth building its technology stack, filing products with state regulators, and securing licensing before going live. The company distributes exclusively through agencies, brokers, and affinity partners rather than direct-to-consumer, and is backed by a panel of carriers including Fidelity Security Life, alongside binders with other markets including Lloyd’s of London.

Why “Income Insurance,” Not “Disability Insurance”

This is Asteya’s core positioning decision, and Hadi’s reasoning goes beyond marketing polish. His framing: life insurance is easy to sell because death is inevitable — nobody argues with the premise that they’ll eventually need it. Disability insurance carries the opposite psychological problem: buying it requires believing something bad might happen to you specifically, which most healthy people simply don’t want to confront. Reframing the product around income protection — the actual financial function it serves — sidesteps that resistance by focusing on the concrete, undeniable exposure (loss of income) rather than the uncomfortable premise (personal misfortune).

He also corrected a common misconception directly: most people associate disability insurance with accidents — a broken leg, a car crash. The actual claims data tells a different story: fewer than 10% of claims are accident-related. The overwhelming majority stem from illness — diabetes, cancer, musculoskeletal conditions — the kind of gradual, unglamorous health deterioration nobody plans around. His anecdote: a podcast editor with carpal tunnel syndrome, functionally unable to work in her own field, who had never even considered that a product existed to protect against exactly that scenario.

The Real Exposure: Living Paycheck to Paycheck, Regardless of Income

Hadi’s sharpest statistic reframes who actually needs this coverage. Roughly half of the US population lives paycheck to paycheck — a category that includes plenty of high earners, not just low-income households. His point: a person earning $1 million a year but spending against that income with no buffer carries functionally the same acute risk as an unemployed person with no income at all, the moment illness or injury interrupts their earnings. Mortgage, debt service, children’s school fees, lifestyle expenses — none of that pauses just because income does.

Guaranteed Renewability: A Genuinely Rare Pricing Structure

This was the most concrete product mechanic in the conversation, and worth understanding because it’s structurally unusual compared to most personal insurance lines. Certain Asteya products carry guaranteed renewability: buy the policy at 30, keep paying the same premium, and the price doesn’t change through age 60 — as long as premiums are paid continuously. Hadi contrasted this directly against auto insurance (repriced essentially every year), health insurance (repriced as you age), and even term life (price increases as the term renews with age). His practical advice on timing: the ideal buyer is someone in their 30s who has established real income, taken on mortgage or family obligations, and has enough financial discipline to commit — younger buyers in their 20s technically qualify but tend to prioritize consumption over this kind of forward protection.

How Asteya Actually Serves Its Distribution Partners

Asteya doesn’t sell direct-to-consumer at all — its entire go-to-market runs through agents, brokers, and affinity partners, and Hadi’s description of the workflow is a clean illustration of how a modern MGU can meaningfully compress an agent’s sales cycle:

• Asteya trains partner agents to look at an existing client’s coverage and identify a specific income-protection gap — someone who already has life insurance or critical illness coverage but nothing addressing non-fatal loss of income
• Once the agent and client agree on a benefit amount and budget, the agent sends a single enrollment link
• The client completes the application (5-7 minutes), enters payment, and the policy issues digitally — with no back-and-forth between agent, carrier, and underwriter required

Hadi’s framing of the commercial upside for agents: this isn’t just filling a genuine coverage gap for the client, it materially shortens the agent’s own sales cycle and accelerates their own commission timeline, while Asteya absorbs the administrative overhead the agent would otherwise have to manage manually.

Why He Thinks Insurtech’s First Wave Got Disintermediation Wrong

This was the sharpest strategic argument in the conversation, and it’s a direct rebuttal of the “cut out the agent” thesis that defined a lot of early insurtech funding.

Hadi’s case: eliminating the agent doesn’t actually eliminate the underlying cost — a direct-to-consumer company still needs people who understand insurance to do the agent’s job, they just become salaried employees instead of commissioned intermediaries, so the cost doesn’t disappear, it relocates. Worse, replacing the agent removes the trust mechanism the entire transaction depends on — insurance is fundamentally a promise of future payment for a possible future event, and Hadi’s blunt framing: nobody hands over money to a stranger’s promise without either personal trust or a genuinely expensive brand behind it. He pointed to the marketing spend disclosed in several public insurtechs’ financials — $80-90 million a year in some cases — as the direct cost of trying to manufacture that trust at scale without an agent relationship to carry it.

His read on how the market corrected: early insurtech “sold the narrative” ahead of the underlying fundamentals, and as investors got burned and grew more sophisticated across multiple cycles, the discipline shifted toward loss ratio, cost ratio, and genuine unit economics — the same top-25 carriers that have dominated the US market for decades remain dominant precisely because their slow, regulated, risk-disciplined approach is structurally correct for a business where mistakes break your balance sheet, not just your growth metrics.

Bundling With Term Life, Not Competing Against It

Asked how Asteya relates to the more familiar life insurance conversation an agent typically leads with, Hadi framed the two products as genuinely complementary rather than substitutes. Both protect income; the difference is the trigger — death for term life, illness/injury/sickness for disability — and both are needed in a complete protection portfolio, since neither addresses the other’s specific risk. Asteya has partnered with providers specifically to bundle term life and disability coverage together, positioning them as a paired offering an agent presents as one conversation rather than two separate pitches.

Underwriting Discipline as the Actual Differentiator

Hadi was explicit that Asteya’s core philosophy is profitability-first, not growth-at-any-cost. His framing of the risk in the opposite approach: a company can grow its top line indefinitely, but if loss ratio exceeds 100% or customer acquisition cost exceeds lifetime value, the business is structurally unsustainable regardless of growth rate — precisely the trap that caught a wave of earlier, more heavily funded insurtechs once capital markets tightened and continued funding could no longer paper over negative unit economics. Asteya’s stated approach: build the top line, but treat cost efficiency, automation, and disciplined hiring as first-order priorities from day one, not problems to solve later once scale justifies it.

Why Predictive, Biometric-Based Underwriting Isn’t Here Yet — But Should Be

I asked Hadi directly whether Asteya’s own biometric-tracking culture translates into using lifestyle or biological-age data in underwriting. His answer was candid about the regulatory reality rather than the technical possibility: filing a product requires filing the specific rating factors and underwriting questions with regulators in advance, and predictive analytics based on evolving biomarker data doesn’t fit cleanly into that static, filed-rate structure the way traditional actuarial mortality tables do.

His conceptual argument for where this should eventually go: insurers underwrite based on calendar age when the more accurate signal would be biological age — a 50-year-old with diabetes in cancer remission carries meaningfully different risk than a 50-year-old who doesn’t smoke, exercises daily, and eats a genuinely healthy diet, yet both are priced identically today. Actually integrating that distinction into underwriting requires convincing carriers, regulators, and underwriters simultaneously — a slow, multi-party consensus problem, not a technology limitation. His broader point: the industry currently pools healthy and unhealthy risk together in a way that, in his view, subsidizes bad risk at good risk’s expense — a dynamic he’d like to see change, even acknowledging Asteya alone can’t force that shift.

Advice: Cut the Sugar

Asked for closing advice, Hadi went personal rather than professional: eliminate sugar as much as realistically possible, given how deeply embedded it is in the American food supply — including in foods that don’t read as sweet, like sushi rice. His practical framing, aware that full elimination is unrealistic for most people: start by simply becoming aware of the ingredient and reducing it, replacing it where possible with healthy fats (olive oil, avocado oil) rather than attempting total abstinence.

Key Takeaways

• Reframing disability insurance as “income insurance” directly addresses the psychological resistance to buying coverage against a misfortune people don’t want to imagine happening to them
• Fewer than 10% of disability claims are accident-related — the overwhelming majority stem from illness, a fact most consumers (and even some professionals in adjacent fields) simply aren’t aware of
• Living paycheck to paycheck creates genuine income-protection exposure regardless of income level — a high earner with no financial buffer carries similar acute risk to someone unemployed
• Guaranteed renewability, locking in the same premium for decades as long as payments continue, is a structurally rare pricing mechanic worth understanding as a genuine product differentiator against most other insurance lines
• Eliminating the agent doesn’t eliminate underlying distribution cost — it relocates it into salaried staff and expensive brand-building, while also removing the trust mechanism that makes the insurance transaction possible in the first place
• Term life and disability/income insurance are complementary, not competing, products — different triggers, same underlying protection function, and increasingly sold bundled together
• Profitability-first underwriting discipline — not growth-at-any-cost — is what separates the current, more mature wave of insurtech from the funding-driven excesses of the earlier cycle
• Biological-age-based underwriting is conceptually compelling but structurally blocked by how insurance products are filed and regulated today, requiring multi-party consensus (carrier, regulator, underwriter) rather than just better technology